76%
de las cuentas minoristas pierden dinero al operar CFDs con este proveedor.
Las inversiones conllevan riesgos y no son adecuadas para todos los inversores. Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
76%
de inversores minoristas pierden dinero cuando operan con CFDs con este proveedor.
Debes considerar si entiendes cómo funcionan los CFDs, y si puedes permitirte asumir el alto riesgo de perder tu dinero.
76%
de las cuentas minoristas pierden dinero al operar CFDs con este proveedor.
Las inversiones conllevan riesgos y no son adecuadas para todos los inversores. Los CFDs son instrumentos complejos y tienen un alto riesgo de perder dinero rápidamente debido al apalancamiento.
76%
de inversores minoristas pierden dinero cuando operan con CFDs con este proveedor.
Debes considerar si entiendes cómo funcionan los CFDs, y si puedes permitirte asumir el alto riesgo de perder tu dinero.
Español (Latinoamérica)
Afya Ltd (Class A)
Cerrado
SectorConsumo defensivo
17.51 -0.34
Resumen
Variación precio
24h
Mínimo
17.17
Máximo
17.62
Ingresos | 102M 252M |
|---|---|
Ventas | 87M 936M |
P/B Media del Sector | 12.669 40.441 |
BPA | 3.2 |
Rentabilidad por dividendo | 1.35 |
Margen de beneficio | 26.913 |
EBITDA | 173M 480M |
Recomendaciones | Vender |
|---|---|
Estimación a 12 meses | +17.31% upside |
Rentabilidad por dividendo Media del Sector | 1.35% 3.42% |
|---|---|
Próximas Ganancias | 14 ago 2025 |
Capitalización de Mercado | -155M 1.6B |
|---|---|
Apertura anterior | 17.85 |
Cierre anterior | 17.51 |
Noticias sobre sentimiento de mercado
By Acuity
50%
50%
66 / 151 Clasificación en Consumer defensive
Puntuación técnica
By Trading Central
Confianza
Bullish Evidence
Afya Ltd (Class A) Gráfico
El rendimiento pasado no es un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
Afya Ltd (Class A) Esperado
Precio Objetivo
By TipRanks
17.31% repunte
Estimación a 12 meses
Media 20.67 USD 17.31%
Máximo 23.5 USD
Mínimo 19 USD
De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Afya Ltd (Class A) Dist en los últimos 3 meses.
Sentimiento
By Acuity
66 / 151 Clasificación en Consumo defensivo
Noticias sobre sentimiento de mercado
Neutral
Volatilidad
Por debajo de la media
Volumen de Noticias (RCV)
Por debajo de la media
Finanzas
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$
Acerca de Afya Ltd (Class A)
Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
